<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Pancreatic Cancer Genomics: Immune Modeling & Drug Discovery | Cristea Lab</title>
    <link rel="stylesheet" href="../styles-warm-accent.css">
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <style>
        .research-page {
            margin-top: 100px;
            padding: 3rem 0;
        }
        .research-hero {
            background: linear-gradient(135deg, var(--color-accent), var(--color-accent-hover));
            color: white;
            padding: 4rem 0;
            text-align: center;
            margin-bottom: 4rem;
        }
        .research-hero h1 {
            font-size: 2.5rem;
            margin-bottom: 1rem;
            font-weight: 700;
        }
        .research-hero p {
            font-size: 1.2rem;
            max-width: 800px;
            margin: 0 auto;
            opacity: 0.95;
        }
        .research-section {
            margin-bottom: 4rem;
        }
        .research-section h2 {
            font-size: 2rem;
            color: var(--color-text-primary);
            margin-bottom: 2rem;
            padding-bottom: 0.5rem;
            border-bottom: 2px solid var(--color-accent);
        }
        .project-card {
            background: var(--color-surface-elevated);
            border-radius: var(--radius-xl);
            box-shadow: var(--shadow-sm);
            padding: 2rem;
            margin-bottom: 2rem;
            border: 1px solid var(--color-border);
            transition: var(--transition-normal);
        }
        .project-card:hover {
            box-shadow: var(--shadow-md);
            transform: translateY(-2px);
        }
        .project-card h3 {
            font-size: 1.4rem;
            color: var(--color-text-primary);
            margin-bottom: 1rem;
            font-weight: 600;
        }
        .project-description {
            color: var(--color-text-secondary);
            line-height: 1.7;
            margin-bottom: 1.5rem;
        }
        .key-results {
            background: var(--color-accent-light);
            padding: 1.5rem;
            border-radius: var(--radius-lg);
            margin: 1.5rem 0;
            border-left: 4px solid var(--color-accent);
        }
        .key-results h4 {
            color: var(--color-accent-hover);
            margin-bottom: 0.75rem;
            font-weight: 600;
        }
        .key-results ul {
            list-style-type: none;
            padding: 0;
        }
        .key-results li {
            padding: 0.5rem 0;
            position: relative;
            padding-left: 1.5rem;
        }
        .key-results li::before {
            content: 'â†’';
            position: absolute;
            left: 0;
            color: var(--color-accent);
            font-weight: bold;
        }
        .methodology-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 1.5rem;
            margin: 1.5rem 0;
        }
        .methodology-item {
            background: var(--color-surface);
            padding: 1.5rem;
            border-radius: var(--radius-lg);
            border: 1px solid var(--color-border);
        }
        .methodology-item h5 {
            color: var(--color-text-primary);
            margin-bottom: 0.5rem;
            font-weight: 600;
        }
        .tech-stack {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin: 1rem 0;
        }
        .tech-tag {
            background: var(--color-accent);
            color: white;
            padding: 0.3rem 0.8rem;
            border-radius: 15px;
            font-size: 0.85rem;
            font-weight: 500;
        }
        .publication-link {
            display: inline-flex;
            align-items: center;
            gap: 0.5rem;
            color: var(--color-accent);
            text-decoration: none;
            font-weight: 500;
            transition: var(--transition-normal);
            margin-right: 1rem;
        }
        .publication-link:hover {
            color: var(--color-accent-hover);
        }
        .impact-box {
            background: linear-gradient(135deg, var(--color-surface), var(--color-surface-elevated));
            padding: 2rem;
            border-radius: var(--radius-xl);
            border: 1px solid var(--color-border);
            margin: 2rem 0;
        }
        .collaboration-info {
            background: var(--color-surface);
            padding: 1rem;
            border-radius: var(--radius-lg);
            margin: 1rem 0;
            border-left: 3px solid var(--color-accent-medium);
        }
        .collaboration-info p {
            margin: 0;
            font-size: 0.95rem;
            color: var(--color-text-secondary);
        }
        @media (max-width: 768px) {
            .research-hero h1 {
                font-size: 2rem;
            }
            .methodology-grid {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>
<body>
    <!-- Navigation -->
    <nav class="navbar">
        <div class="nav-container">
            <div class="nav-brand">
                <h1>Cristea Lab</h1>
                <span class="nav-subtitle">AI Cancer Genomics Research</span>
            </div>
            <ul class="nav-menu">
                <li><a href="../index.html" class="nav-link">Home</a></li>
                <li><a href="../index.html#research" class="nav-link">Research</a></li>
                <li><a href="../index.html#team" class="nav-link">Team</a></li>
                <li><a href="../publications.html" class="nav-link">Publications</a></li>
                <li><a href="../index.html#software" class="nav-link">Software</a></li>
                <li><a href="../index.html#contact" class="nav-link">Contact</a></li>
            </ul>
            <div class="nav-toggle">
                <span class="bar"></span>
                <span class="bar"></span>
                <span class="bar"></span>
            </div>
        </div>
    </nav>

    <!-- Research Page Content -->
    <div class="research-page">
        <!-- Hero Section -->
        <div class="research-hero">
            <div class="container">
                <h1>Pancreatic Cancer Genomics</h1>
                <p>
                    Integrative immune modeling, drug resistance mechanisms, and target discovery through 
                    single-cell multi-omics, CRISPR screens, and clinical trial data analysis
                </p>
            </div>
        </div>

        <div class="container">
            <!-- Overview -->
            <div class="research-section">
                <h2>Research Overview</h2>
                <div class="project-description">
                    <p>
                        Our laboratory conducts comprehensive genomic analyses of pancreatic cancer, integrating single-cell 
                        transcriptomics, T-cell receptor sequencing, and CRISPR screening to understand treatment response 
                        and resistance mechanisms. We analyze clinical trial data from the Hale Center to identify biomarkers 
                        for immunotherapy response, characterize resistance to KRAS inhibition, and discover novel therapeutic 
                        targets through surface proteome profiling.
                    </p>
                </div>
                
                <div class="impact-box">
                    <h4 style="color: var(--color-accent); margin-bottom: 1rem;">Clinical Impact</h4>
                    <p>
                        Our integrated genomics approach directly impacts patient care by: (1) identifying biomarkers that 
                        predict immunotherapy response, (2) elucidating resistance mechanisms to guide combination therapies, 
                        (3) discovering novel antibody-drug conjugate targets, and (4) creating accessible data resources 
                        that accelerate translational research across the Hale Center.
                    </p>
                </div>
            </div>

            <!-- Part 1: Immune Modeling -->
            <div class="research-section">
                <h2>Integrative Immune Modeling</h2>
                
                <!-- Project A: Immunotherapy Analysis -->
                <div class="project-card">
                    <h3>Single-cell Analysis of Immunotherapy-treated Pancreatic Cancers</h3>
                    <div class="project-description">
                        <p>
                            We analyze scRNA-seq and scTCR-seq data from DFCI clinical trials comparing FOLFIRINOX, 
                            pembrolizumab, and gemcitabine/nab-paclitaxel treatments. Our integrated analysis reveals 
                            treatment-specific immune responses and TCR clonal expansion patterns that correlate with 
                            clinical outcomes.
                        </p>
                    </div>

                    <div class="collaboration-info">
                        <p><strong>Collaboration:</strong> Dr. Chong Zuo (Dr. Stephanie Dougan's lab, DFCI)</p>
                    </div>

                    <div class="key-results">
                        <h4>Key Findings</h4>
                        <ul>
                            <li>FOLFIRINOX drives CD8 T effector memory (Tem) cell expansion</li>
                            <li>Pembrolizumab specifically affects CD8 T effector cells (Teff)</li>
                            <li>Cell2Sentence framework achieves 85% accuracy in cell-type classification</li>
                            <li>Treatment prediction accuracy reaches 95% using fine-tuned LLMs</li>
                        </ul>
                    </div>

                    <div class="methodology-grid">
                        <div class="methodology-item">
                            <h5>Data Integration</h5>
                            <p>Tumor and blood samples with paired TCR sequencing</p>
                        </div>
                        <div class="methodology-item">
                            <h5>LLM Application</h5>
                            <p>Cell2Sentence and scGPT for cellular embeddings</p>
                        </div>
                        <div class="methodology-item">
                            <h5>Clinical Correlation</h5>
                            <p>Survival time and recurrence prediction</p>
                        </div>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">scRNA-seq</span>
                        <span class="tech-tag">scTCR-seq</span>
                        <span class="tech-tag">Immunotherapy</span>
                        <span class="tech-tag">Cell2Sentence</span>
                        <span class="tech-tag">Clinical Trials</span>
                    </div>
                </div>

                <!-- Project B: Data Repository -->
                <div class="project-card">
                    <h3>Hale Center Data Repository</h3>
                    <div class="project-description">
                        <p>
                            We developed a comprehensive data sharing platform for genomic sequencing samples generated 
                            at the Hale Center. The web-based repository enables interactive data exploration, clinical 
                            data integration, and streamlined access to multi-omics datasets for the research community.
                        </p>
                    </div>

                    <div class="key-results">
                        <h4>Platform Features</h4>
                        <ul>
                            <li>Flask-based web application with R and Dash components</li>
                            <li>Interactive data exploration tools</li>
                            <li>Clinical data integration and visualization</li>
                            <li>Secure access within DFCI network/VPN</li>
                        </ul>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">Flask</span>
                        <span class="tech-tag">Python</span>
                        <span class="tech-tag">R</span>
                        <span class="tech-tag">Dash</span>
                        <span class="tech-tag">Data Sharing</span>
                    </div>

                    <div style="margin-top: 1rem;">
                        <a href="http://haledatarepo.dfci.harvard.edu/" class="publication-link" target="_blank">
                            <i class="fas fa-database"></i> Access Repository (DFCI Network)
                        </a>
                        <a href="https://github.com/cristea-lab" class="publication-link" target="_blank">
                            <i class="fab fa-github"></i> GitHub
                        </a>
                    </div>
                </div>

                <!-- Project C: ICB Biomarkers -->
                <div class="project-card">
                    <h3>Biomarkers for Immune Checkpoint Blockade Response</h3>
                    <div class="project-description">
                        <p>
                            We conducted a comprehensive review of prognostic biomarkers for immunotherapy response 
                            across diverse data modalities. Our analysis integrates genetic signatures, genomic features, 
                            and imaging data to improve prediction of patient outcomes after ICB therapy.
                        </p>
                    </div>

                    <div class="key-results">
                        <h4>Review Highlights</h4>
                        <ul>
                            <li>Pan-cancer analysis of ICB biomarkers</li>
                            <li>Integration of multi-omics and imaging features</li>
                            <li>Computational approaches for outcome prediction</li>
                            <li>Challenges in immunotherapy prognostication</li>
                        </ul>
                    </div>

                    <p style="margin-top: 1rem; font-style: italic;">
                        Liu Y et al. "Predicting patient outcomes after treatment with immune checkpoint blockade: 
                        A review of biomarkers derived from diverse data modalities" 
                        <em>Cell Genomics</em> 4, 100444, 2024
                    </p>
                </div>
            </div>

            <!-- Part 2: Drug Resistance -->
            <div class="research-section">
                <h2>Drug Perturbation & Resistance Mechanisms</h2>
                
                <!-- Project A: KRAS Resistance -->
                <div class="project-card">
                    <h3>Mechanisms of Resistance to KRAS Inhibition</h3>
                    <div class="project-description">
                        <p>
                            Using clinical samples and preclinical models, we characterized heterogeneous genetic and 
                            non-genetic mechanisms of resistance to KRAS inhibitors. Our work guides combination therapy 
                            approaches to improve efficacy and durability of these promising treatments.
                        </p>
                    </div>

                    <div class="key-results">
                        <h4>Major Discoveries</h4>
                        <ul>
                            <li>Mutations in PIK3CA and KRAS emerge at resistance</li>
                            <li>Amplifications of KRASG12C, MYC, MET, EGFR, CDK6</li>
                            <li>EMT and PI3K-AKT-mTOR signaling drive resistance</li>
                            <li>Mesenchymal/basal states show increased KRAS inhibitor response</li>
                            <li>Combination with chemotherapy improves tumor control</li>
                        </ul>
                    </div>

                    <div class="methodology-grid">
                        <div class="methodology-item">
                            <h5>Model Systems</h5>
                            <p>KPC mice, organoids, cell lines, PDX models</p>
                        </div>
                        <div class="methodology-item">
                            <h5>Drug Testing</h5>
                            <p>Adagrasib, sotorasib, MRTX1133</p>
                        </div>
                        <div class="methodology-item">
                            <h5>Genomic Analysis</h5>
                            <p>WES, RNA-seq, amplification detection</p>
                        </div>
                    </div>

                    <p style="margin-top: 1rem; font-style: italic;">
                        Dilly J et al. "Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer" 
                        <em>Cancer Discovery</em> 2024
                    </p>

                    <div class="tech-stack">
                        <span class="tech-tag">KRAS Inhibitors</span>
                        <span class="tech-tag">Resistance Mechanisms</span>
                        <span class="tech-tag">Mouse Models</span>
                        <span class="tech-tag">Combination Therapy</span>
                    </div>
                </div>

                <!-- Project B: CRISPR Screens -->
                <div class="project-card">
                    <h3>CRISPR Screening for Pan-RAS vs Mutant-Selective Inhibition</h3>
                    <div class="project-description">
                        <p>
                            We are conducting genome-wide CRISPR screens to compare pan-RAS versus mutant-selective 
                            KRAS inhibitors across multiple pancreatic cancer cell lines. Our novel permutation-based 
                            analysis integrates multiple replicates to identify robust resistance and sensitization genes.
                        </p>
                    </div>

                    <div class="collaboration-info">
                        <p><strong>Collaboration:</strong> Dr. Andrew Aguirre's lab (DFCI/BWH)</p>
                    </div>

                    <div class="methodology-grid">
                        <div class="methodology-item">
                            <h5>Inhibitors Tested</h5>
                            <p>RMC-7977 (pan-RAS), RMC-9945, MRTX1133 (G12D-specific)</p>
                        </div>
                        <div class="methodology-item">
                            <h5>Analysis Focus</h5>
                            <p>Resistance genes, sensitizers, pathway modulation</p>
                        </div>
                        <div class="methodology-item">
                            <h5>Statistical Method</h5>
                            <p>Permutation approach for replicate integration</p>
                        </div>
                    </div>

                    <div class="key-results">
                        <h4>Analysis Questions</h4>
                        <ul>
                            <li>Pan-RAS vs mutant-selective inhibitor differences</li>
                            <li>Universal vs specific resistance mechanisms</li>
                            <li>Common vulnerabilities across inhibitor types</li>
                            <li>Protein-protein interaction networks in resistance</li>
                        </ul>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">CRISPR Screening</span>
                        <span class="tech-tag">RAS Inhibitors</span>
                        <span class="tech-tag">Genetic Dependencies</span>
                        <span class="tech-tag">Drug Resistance</span>
                    </div>
                </div>

                <!-- Project C: Phage Display -->
                <div class="project-card">
                    <h3>PhageDisplay Antibody Screening for Novel Targets</h3>
                    <div class="project-description">
                        <p>
                            We employ PhageDisplay technology to identify novel cell surface targets in KRAS 
                            inhibitor-resistant pancreatic cancer. Our VHH antibody library screening reveals 
                            targetable proteins for developing next-generation antibody-drug conjugates.
                        </p>
                    </div>

                    <div class="methodology-grid">
                        <div class="methodology-item">
                            <h5>Experimental Design</h5>
                            <p>5 conditions: parental/resistant, baseline/treated</p>
                        </div>
                        <div class="methodology-item">
                            <h5>Technology</h5>
                            <p>VHH phage library, NGS sequencing</p>
                        </div>
                        <div class="methodology-item">
                            <h5>Analysis Platform</h5>
                            <p>dBio Abgenesis for clonotype clustering</p>
                        </div>
                    </div>

                    <div class="key-results">
                        <h4>Screening Approach</h4>
                        <ul>
                            <li>Positive selection on pancreatic cancer cells</li>
                            <li>Negative selection on 293T cells</li>
                            <li>Multiple enrichment rounds</li>
                            <li>High-throughput sequencing of enriched VHH</li>
                        </ul>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">PhageDisplay</span>
                        <span class="tech-tag">Antibody Discovery</span>
                        <span class="tech-tag">Surface Proteome</span>
                        <span class="tech-tag">ADC Targets</span>
                    </div>
                </div>
            </div>

            <!-- Publications -->
            <div class="research-section">
                <h2>Selected Publications</h2>
                <div class="project-card">
                    <div class="project-description">
                        <p><strong>Dilly J</strong>, Hoffman MT, Abbassi L, ... <strong>Cristea S</strong>, ... Aguirre AJ. 
                        "Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer" 
                        <em>Cancer Discovery</em>, 2024.</p>
                        
                        <p style="margin-top: 1rem;"><strong>Liu Y</strong>, Altreuter J, Bodapati S, <strong>Cristea S</strong>, Wong CJ, Wu CJ, Michor F. 
                        "Predicting patient outcomes after treatment with immune checkpoint blockade: A review of biomarkers derived from diverse data modalities" 
                        <em>Cell Genomics</em> 4, 100444, 2024.</p>
                    </div>
                </div>
            </div>

            <!-- Future Directions -->
            <div class="research-section">
                <h2>Future Directions</h2>
                <div class="impact-box">
                    <p>
                        We are expanding our pancreatic cancer genomics research to include: (1) multi-modal integration 
                        of spatial transcriptomics with immune profiling, (2) development of resistance prediction models 
                        using machine learning, (3) validation of novel ADC targets in preclinical models, and (4) 
                        prospective biomarker validation in clinical trials. Our goal is to translate genomic insights 
                        into actionable therapeutic strategies that improve patient outcomes.
                    </p>
                </div>
            </div>

            <!-- Back Navigation -->
            <div class="text-center" style="margin-top: 3rem;">
                <a href="../index.html#research" class="btn btn-secondary">Back to Research Overview</a>
            </div>
        </div>
    </div>

    <!-- Footer -->
    <footer class="footer">
        <div class="container">
            <div class="footer-content">
                <div class="footer-logo">
                    <h3>Cristea Lab</h3>
                    <p>AI Cancer Genomics Research</p>
                </div>
                <div class="footer-links">
                    <a href="https://www.dana-farber.org" target="_blank">Dana-Farber Cancer Institute</a>
                    <a href="https://www.harvard.edu" target="_blank">Harvard University</a>
                </div>
                <div class="footer-social">
                    <a href="#" class="social-link"><i class="fab fa-twitter"></i></a>
                    <a href="#" class="social-link"><i class="fab fa-github"></i></a>
                    <a href="#" class="social-link"><i class="fab fa-linkedin"></i></a>
                </div>
            </div>
            <div class="footer-bottom">
                <p>&copy; 2025 Cristea Lab. All rights reserved.</p>
            </div>
        </div>
    </footer>

    <script src="../script-clean-modern.js"></script>
</body>
</html>